Cargando…
Implications of fluorodeoxyglucose uptake in low-intermediate grade metastatic neuroendocrine tumors from peptide receptor radionuclide therapy outcome viewpoint: A semi-quantitative standardized uptake value-based analysis
Dual tracer positron emission tomography (PET) imaging approach (with (68)Ga-DOTATATE PET-computed tomography (CT) for somatostatin receptor and 18-fluorodeoxyglucose ((18)FDG) PET-CT for glucose transporter receptor) plays a vital role in baseline differentiation, treatment decision-making, and pro...
Autores principales: | Adnan, Aadil, Sampathirao, Nikita, Basu, Sandip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945359/ https://www.ncbi.nlm.nih.gov/pubmed/31933555 http://dx.doi.org/10.4103/wjnm.WJNM_62_18 |
Ejemplares similares
-
Somatostatin Receptor Targeted PET-CT and Its Role in the Management and Theranostics of Gastroenteropancreatic Neuroendocrine Neoplasms
por: Adnan, Aadil, et al.
Publicado: (2023) -
(177)Lu-DOTATATE Peptide Receptor Radionuclide Therapy in Metastatic or Advanced and Inoperable Primary Neuroendocrine Tumors of Rare Sites
por: Thapa, Pradeep, et al.
Publicado: (2017) -
Uptake of Radionuclides by Bryophytes in the Chornobyl Exclusion Zone
por: Schmidt, Brigitte, et al.
Publicado: (2023) -
Primary pancreatic lymphoma camouflaged under the umbrella of spectrum of neuroendocrine tumors in somatostatin receptor imaging
por: Sampathirao, Nikita, et al.
Publicado: (2020) -
Peptide Receptor Radionuclide Therapy with (177)Lu-DOTATATE for Metastatic Neuroendocrine Tumor Occurring in Association with Multiple Endocrine Neoplasia Type 1 and Cushing's Syndrome
por: Naik, Chinna, et al.
Publicado: (2017)